Journal of Shanghai Jiao Tong University (Medical Science) ›› 2024, Vol. 44 ›› Issue (4): 525-530.doi: 10.3969/j.issn.1674-8115.2024.04.014
• Review • Previous Articles
LIU Linnan(), FENG Li, WANG Long, LIU Jiayin, FAN Zhisong()
Received:
2023-10-09
Accepted:
2024-02-16
Online:
2024-04-28
Published:
2024-04-28
Contact:
FAN Zhisong
E-mail:lln960714@163.com;fanzs@hebmu.edu.cn
Supported by:
CLC Number:
LIU Linnan, FENG Li, WANG Long, LIU Jiayin, FAN Zhisong. Research progress in the expression of versican in malignant tumors and its biological roles[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(4): 525-530.
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.shsmu.edu.cn/EN/10.3969/j.issn.1674-8115.2024.04.014
1 | ISLAMI F, WARD E M, SUNG H, et al. Annual report to the nation on the status of cancer, part 1: national cancer statistics[J]. J Natl Cancer Inst, 2021, 113(12): 1648-1669. |
2 | CHEVRIER S, LEVINE J H, ZANOTELLI V R T, et al. An immune atlas of clear cell renal cell carcinoma[J]. Cell, 2017, 169(4): 736-749.e18. |
3 | KARAGIORGOU Z, FOUNTAS P N, MANOU D, et al. Proteoglycans determine the dynamic landscape of EMT and cancer cell stemness[J]. Cancers, 2022, 14(21): 5328. |
4 | KESH K, GUPTA V K, DURDEN B, et al. Therapy resistance, cancer stem cells and ECM in cancer: the matrix reloaded[J]. Cancers, 2020, 12(10): 3067. |
5 | HIRANI P, GAUTHIER V, ALLEN C E, et al. Targeting versican as a potential immunotherapeutic strategy in the treatment of cancer[J]. Front Oncol, 2021, 11: 712807. |
6 | MITSUI Y, SHIINA H, KATO T, et al. Versican promotes tumor progression, metastasis and predicts poor prognosis in renal carcinoma[J]. Mol Cancer Res, 2017, 15(7): 884-895. |
7 | 吕磊, 郑福鑫, 周高峰, 等. 多功能蛋白聚糖基因对膀胱尿路上皮癌免疫浸润及预后的影响[J]. 解放军医学杂志, 2023, 48(8): 921-928. |
LÜ L, ZHENG F X, ZHOU G F, et al. Effect of VCAN on immune infiltration and prognosis of bladder urothelial carcinoma[J]. Medical Journal of Chinese People's Liberation Army, 2023, 48(8): 921-928. | |
8 | SUN G S, ZHENG W B, TAN P Y, et al. Comprehensive analysis of VCAN expression profiles and prognostic values in HCC[J]. Front Genet, 2022, 13: 900306. |
9 | KATO K, FUKAI M, HATANAKA K C, et al. Versican secreted by cancer-associated fibroblasts is a poor prognostic factor in hepatocellular carcinoma[J]. Ann Surg Oncol, 2022, 29(11): 7135-7146. |
10 | WANG M Q, LI Y P, XU M, et al. VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors[J]. World J Gastrointest Oncol, 2022, 14(10): 1933-1948. |
11 | DE WIT M, CARVALHO B, DELIS-VAN DIEMEN P M, et al. Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression[J]. PLoS One, 2017, 12(5): e0174768. |
12 | GUO J, LIU Y. INHBA promotes the proliferation, migration and invasion of colon cancer cells through the upregulation of VCAN[J]. J Int Med Res, 2021, 49(6): 3000605211014998. |
13 | WANG L, FENG L, LIU L N, et al. Joint effect of THBS2 and VCAN accelerating the poor prognosis of gastric cancer[J]. Aging, 2023, 15(5): 1343-1357. |
14 | SONG J Q, WEI R Y, HUO S Y, et al. Versican enrichment predicts poor prognosis and response to adjuvant therapy and immunotherapy in gastric cancer[J]. Front Immunol, 2022, 13: 960570. |
15 | ZHAI L L, CHEN W J, CUI B S, et al. Overexpressed versican promoted cell multiplication, migration and invasion in gastric cancer[J]. Tissue Cell, 2021, 73: 101611. |
16 | CHENG Y, SUN H Z, WU L L, et al. VUp-regulation of VCAN promotes the proliferation, invasion and migration and serves as a biomarker in gastric cancer[J]. Onco Targets Ther, 2020, 13: 8665-8675. |
17 | PAPADAS A, ARAUZ G, CICALA A, et al. Versican and versican-matrikines in cancer progression, inflammation, and immunity[J]. J Histochem Cytochem, 2020, 68(12): 871-885. |
18 | WU Y J, LA PIERRE D P, WU J, et al. The interaction of versican with its binding partners[J]. Cell Res, 2005, 15(7): 483-494. |
19 | PAPADAS A, ASIMAKOPOULOS F. Versican in the tumor microenvironment[J]. Adv Exp Med Biol, 2020, 1272: 55-72. |
20 | KERN C B, NORRIS R A, THOMPSON R P, et al. Versican proteolysis mediates myocardial regression during outflow tract development[J]. Dev Dyn, 2007, 236(3): 671-683. |
21 | HAYES A, SUGAHARA K, FARRUGIA B, et al. Biodiversity of CS-proteoglycan sulphation motifs: chemical messenger recognition modules with roles in information transfer, control of cellular behaviour and tissue morphogenesis[J]. Biochem J, 2018, 475(3): 587-620. |
22 | KAMIYA N, WATANABE H, HABUCHI H, et al. Versican/PG-M regulates chondrogenesis as an extracellular matrix molecule crucial for mesenchymal condensation[J]. J Biol Chem, 2006, 281(4): 2390-2400. |
23 | FENG J, LI Y D, LI Y, et al. Versican promotes cardiomyocyte proliferation and cardiac repair[J]. Circulation, 2024, 149(13): 1004-1015. |
24 | WIGHT T N, KANG I, MERRILEES M J. Versican and the control of inflammation[J]. Matrix Biol, 2014, 35: 152-161. |
25 | MATSUMOTO K, SHIONYU M, GO M, et al. Distinct interaction of versican/PG-M with hyaluronan and link protein[J]. J Biol Chem, 2003, 278(42): 41205-41212. |
26 | DAY A J, MILNER C M. TSG-6: a multifunctional protein with anti-inflammatory and tissue-protective properties[J]. Matrix Biol, 2019, 78-79: 60-83. |
27 | WIGHT T N, KANG I, EVANKO S P, et al. Versican: a critical extracellular matrix regulator of immunity and inflammation[J]. Front Immunol, 2020, 11: 512. |
28 | TOCCHI A, PARKS W C. Functional interactions between matrix metalloproteinases and glycosaminoglycans[J]. FEBS J, 2013, 280(10): 2332-2341. |
29 | KANG I, HARTEN I A, CHANG M Y, et al. Versican deficiency significantly reduces lung inflammatory response induced by polyinosine-polycytidylic acid stimulation[J]. J Biol Chem, 2017, 292(1): 51-63. |
30 | DUTT S, KLÉBER M, MATASCI M, et al. Versican V0 and V1 guide migratory neural crest cells[J]. J Biol Chem, 2006, 281(17): 12123-12131. |
31 | WU Y J, SHENG W, CHEN L W, et al. Versican V1 isoform induces neuronal differentiation and promotes neurite outgrowth[J]. Mol Biol Cell, 2004, 15(5): 2093-2104. |
32 | MERRILEES M J, BEAUMONT B W, BRAUN K R, et al. Neointima formed by arterial smooth muscle cells expressing versican variant V3 is resistant to lipid and macrophage accumulation[J]. Arterioscler Thromb Vasc Biol, 2011, 31(6): 1309-1316. |
33 | KANG I, YOON D W, BRAUN K R, et al. Expression of versican V3 by arterial smooth muscle cells alters tumor growth factor β (TGFβ)-, epidermal growth factor (EGF)-, and nuclear factor κB (NFκB)-dependent signaling pathways, creating a microenvironment that resists monocyte adhesion[J]. J Biol Chem, 2014, 289(22): 15393-15404. |
34 | KISCHEL P, WALTREGNY D, DUMONT B, et al. Versican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targeting[J]. Int J Cancer, 2010, 126(3): 640-650. |
35 | ZHANGYUAN G Y, WANG F, ZHANG H T, et al. VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway[J]. Oncogene, 2020, 39(6): 1213-1230. |
36 | TAN R Y, ZHANG G H, LIU R C, et al. Identification of early diagnostic and prognostic biomarkers via WGCNA in stomach adenocarcinoma[J]. Front Oncol, 2021, 11: 636461. |
37 | 陆思芬, 魏小珍, 牟必琴, 等. 基于生物信息数据探究VCAN在食管鳞状细胞癌预后中的作用[J]. 中国胸心血管外科临床杂志, 2022, 29(8): 1031-1041. |
LU S F, WEI X Z, MOU B Q, et al. Exploring the role of VCAN in the prognosis of esophageal squamous cell carcinoma based on bioinformatics data[J]. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2022, 29(8): 1031-1041. | |
38 | YAMAUCHI N, KANKE Y, SAITO K, et al. Stromal expression of cancer-associated fibroblast-related molecules, versican and lumican, is strongly associated with worse relapse-free and overall survival times in patients with esophageal squamous cell carcinoma[J]. Oncol Lett, 2021, 21(6): 445. |
39 | DESJARDINS M, XIE J, GURLER H, et al. Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids[J]. J Ovarian Res, 2014, 7: 70. |
40 | DU W W, YANG W N, YEE A J. Roles of versican in cancer biology: tumorigenesis, progression and metastasis[J]. Histol Histopathol, 2013, 28(6): 701-713. |
41 | YANG B L, ZHANG Y, CAO L, et al. Cell adhesion and proliferation mediated through the G1 domain of versican[J]. J Cell Biochem, 1999, 72(2): 210-220. |
42 | XUE J P, CHEN J N, SHEN Q, et al. Addition of high molecular weight hyaluronic acid to fibroblast-like stromal cells modulates endogenous hyaluronic acid metabolism and enhances proteolytic processing and secretion of versican[J]. Cells, 2020, 9(7): 1681. |
43 | CATTARUZZA S, SCHIAPPACASSI M, KIMATA K, et al. The globular domains of PG-M/versican modulate the proliferation-apoptosis equilibrium and invasive capabilities of tumor cells[J]. FASEB J, 2004, 18(6): 779-781. |
44 | SHENG W, WANG G Z, WANG Y, et al. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis[J]. Mol Biol Cell, 2005, 16(3): 1330-1340. |
45 | CHEN H, ZHAO Y, ZHANG J J, et al. Promoting effects of miR-135b on human multiple myeloma cells via regulation of the Wnt/β-catenin/versican signaling pathway[J]. Cytokine, 2021, 142: 155495. |
46 | ANG L C, ZHANG Y, CAO L, et al. Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain[J]. J Neuropathol Exp Neurol, 1999, 58(6): 597-605. |
47 | YEUNG T L, LEUNG C S, WONG K K, et al. TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment[J]. Cancer Res, 2013, 73(16): 5016-5028. |
48 | 杨迷玲, 杨金花, 王娜, 等. Versican与胃癌上皮-间质转化相关蛋白的表达及意义[J]. 医学研究杂志, 2022, 51(12): 69-74. |
YANG M L, YANG J H, WANG N, et al. Expression of versican and its relationship with epithelial-mesenchymal transition related proteins and clinical significance in gastric cancer[J]. Journal of Medical Research, 2022, 51(12): 69-74. | |
49 | DU W W, FANG L, YANG W N, et al. The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro: evaluation towards understanding breast cancer cell bone metastasis[J]. BMC Cancer, 2012, 12: 341. |
50 | DOS REIS D C, DAMASCENO K A, DE CAMPOS C B, et al. Versican and tumor-associated macrophages promotes tumor progression and metastasis in canine and murine models of breast carcinoma[J]. Front Oncol, 2019, 9: 577. |
51 | ZHENG P S, WEN J P, ANG L C, et al. Versican/PG-M G3 domain promotes tumor growth and angiogenesis[J]. FASEB J, 2004, 18(6): 754-756. |
52 | LABROPOULOU V T, THEOCHARIS A D, RAVAZOULA P, et al. Versican but not decorin accumulation is related to metastatic potential and neovascularization in testicular germ cell tumours[J]. Histopathology, 2006, 49(6): 582-593. |
53 | EVANKO S P, POTTER-PERIGO S, BOLLYKY P L, et al. Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration[J]. Matrix Biol, 2012, 31(2): 90-100. |
54 | POTTER-PERIGO S, JOHNSON P Y, EVANKO S P, et al. Polyinosine-polycytidylic acid stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion[J]. Am J Respir Cell Mol Biol, 2010, 43(1): 109-120. |
55 | KAUR A, ECKER B L, DOUGLASS S M, et al. Remodeling of the collagen matrix in aging skin promotes melanoma metastasis and affects immune cell motility[J]. Cancer Discov, 2019, 9(1): 64-81. |
[1] | WEI Lanyi, XUE Xiaochuan, CHEN Junjun, YANG Quanjun, WANG Mengyue, HAN Yonglong. Research progress of tumor-associated macrophages in immune microenvironment and targeted therapy of osteosarcoma [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(5): 624-630. |
[2] | WANG Wenbo, ZHANG Fangrong, SHI Tingwang, CHEN Yunfeng. Advances in fluorescence imaging of malignant tumors [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(4): 474-479. |
[3] | TANG Lei, XU Yingchun, ZHANG Fengchun. Review of the role of collagen in tumorigenesis and development [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(12): 1577-1584. |
[4] | WU Ruifang, FENG Ming, MENG Jian. Review of role of fatty acid binding protein-4 in obesity-associated tumors [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(10): 1311-1316. |
[5] | MA Fangfang, QIN Jiejie, REN Lingjie, TANG Xiaomei, LIU Jia, SHI Minmin, JIANG Lingxi. Establishment of a 3D culture model in vitro of pancreatic cancer primary cells using hydrogel microspheres [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(1): 79-87. |
[6] | LIN Jiayu, QIN Jiejie, JIANG Lingxi. Progress in metabolism of the immune cells in tumor microenvironment [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(8): 1122-1130. |
[7] | WANG Yuxin, SUN Ruiqi, LIU Jianhua, HE Weina. Development of pH-responsive fluorescent probe for tumor microenvironment imaging [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(7): 875-884. |
[8] | ZHU Nan, LIU Bingya, YU Beiqin. Advances in the role of muscle blind-like protein 1 in malignant tumors [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(10): 1474-1481. |
[9] | Jing-wei LI, Li-wen WANG, Ling-xi JIANG, Qian ZHAN, Hao CHEN, Bai-yong SHEN. Review of immunosuppressive tumor microenvironment of pancreatic cancer [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(8): 1103-1108. |
[10] | Paerhati NADINA, Yan YAN, Qian-ji CHE, Jing LUO, Xin-nan LIU, Bin LI. Application and prospect of chimeric antigen receptor-modified T cell therapy for glioblastoma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(7): 982-986. |
[11] | Ting-wei LU, Jian-jun ZHANG, Wan-tao CHEN. Mechanisms related to regulation of natural killer cell activity by exosomes derived from malignant tumor cells [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(5): 659-664. |
[12] | Xiao-zhi SUN, Shuang LI, Ying JIN, Bing LIAO. Effect of enzyme digestion into cell clumps on protein levels of OCT4 and SOX2 in human embryonic stem cells [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(4): 413-420. |
[13] | Qi-sheng GU, Mi-li ZHANG, Can CAO, Ji-kun LI. Association of alternative splicing and tumor immune in gastric cancer based on TCGA data set [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(4): 448-458. |
[14] | Meng-ke LIU, Meng-meng JI, Lin CHENG, Jin-yan HUANG, Xiao-jian SUN, Wei-li ZHAO, Li WANG. Research progress in anti-tumor effect and mechanism of baicalin [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 246-250. |
[15] | Li-hui WANG, Zhen WANG, Huan WANG, Hong LI, Hui JIANG, Jing-bo SHAO. Malignant tumor complicated with bone marrow necrosis in children: a report of 2 cases with literature review [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(10): 1401-1404. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||